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Background: Oesophageal resection is notoriously complicated and produces a cohort of patients prone
to postoperative complications. Maintaining quality care demands a systematic approach to patient
management yet postoperative recovery after oesophagectomy is often needlessly inefﬁcient, hetero-
geneous and governed by the idiosyncrasies of the operating surgeon. Enhanced recovery after surgery
(ERAS) programmes are now well established in colorectal surgery and here we describe the imple-
mentation and effectiveness of an ERAS programme for the postoperative management of Ivor Lewis
oesophago-gastrectomy (ILOG).
Methods: An ERAS programme was devised and implemented with the support of a dedicated in-
hospital task-force. Three consultant surgeons allocated consecutive patients to the programme (ERAS)
and outcomes were compared to consecutive patients not on the ERAS programme (non-ERAS) and a
pre-ERAS cohort (pre-ERAS). Principal outcome measures were total length of stay (TLOS), Accordion
postoperative complication grade and 30-day readmission rate.
Results: 75 patients were enrolled on the ERAS programme, 41 continued as a non-ERAS cohort and 80
consecutive pre-ERAS patients were identiﬁed. A signiﬁcant improvement in median TLOS was observed
in the ERAS group (10 days r.7e58) compared to pre-ERAS (13 days r. 8e57) (p ¼ <0.001) and non-ERAS
patients (13 days r.8e42) (p ¼ <0.001). No signiﬁcant difference in Accordion scores for postoperative
complications or 30-day readmission rates were observed.
Discussion: The introduction of an ERAS programme after ILOG can signiﬁcantly reduce TLOS without
jeopardising patient safety or clinical outcomes. The successful introduction of an ERAS programme
requires full motivation and support from all team members including the patient.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The evolution of high-volume centres for oesophago-gastric
surgery has created an environment capable of supporting the
dedicated infrastructure and breadth of multi-disciplinary experi-
ence required to deliver consistently high quality outcomes [1,2].
Oesophageal resection is notoriously complicated and produces a
cohort of patients particularly prone to peri-operative morbidity
and mortality [3,4]. Maintaining quality care demands a compre-
hensive and systematic approach to patient management with the
formulation of standardised clinical care pathways [5,6]. Such
pathways optimise every aspect of patient care from initial referral
through to postoperative follow-up, improving outcomes andciates Ltd. Published by Elsevier Ltreducing costs [5,6]. However, the immediate postoperative re-
covery phase after major oesophageal resection often remains
faithful to the idiosyncrasies of the individual operating surgeon
leading to inefﬁcient patient progression and needlessly prolonged
inpatient stay. Enhanced recovery after surgery (ERAS) pro-
grammes are nowwell established in colorectal surgery, driven by a
multi-disciplinary approach that aims to ally the expectations of
surgeons, nursing staff, physiotherapists, dieticians and most
importantly the patient, to facilitate an accelerated and safe hos-
pital discharge [7,8]. Considering that published series report an
inpatient post-oesophagectomy stay of between 11 and 26 days
[3,5,9,10] and that the potential beneﬁts of ERAS programmes have
been clearly demonstrated in other cancer care pathways, we wish
to focus attention to replicate this success in major oesophago-
gastric resections.
Here we describe the implementation and effectiveness of a
goal-directed ERAS programme for the postoperative managementd. All rights reserved.
Table 1
Enhanced recovery after surgery programme for ILOG patients implemented at the Peninsula Oesophago-Gastric Surgery Unit, Derriford Hospital, October 2011.
Day of Operation (Day 0) Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
Monitoring Hourly observations
Heart monitor
attached
Humidiﬁed
oxygen via
mask TED
stockings in situ
2e4 hourly obs
Hourly
urine Remove heart
monitor
TEDS e removed,
legs checked,
replaced daily
4e6 hourly obs
Hourly urine
Stop Oxygen 6 hourly obs 6 hourly obs
Pain Control Epidural, PCA or
Paravertebral IV
paracetamol
Diclofenac PR if
required
Remove
epidural /
paravertebral
Oral analgesia
Exercise Supported to lie
upright in bed
Sit out in chair
(depend time
get to ward) Leg
movements
in bed Breathing
exercises
using incentive
spirometer
Sit out in chair
Support patient
to mobilise
x4 times per day
Other exercise
as per Day 0
NG Tube In place Spigot (4e6
hrly aspirates)
Consider
removal
Chest Drains In place Consider
removal 1
chest drain
Consider
removal 2nd
& 3rd (left
sided) if
present
Abdominal
Drain
In place Consider
removal
Urinary
Catheter
In place Consider
removal
Central Line In place Consider
removal
IV Fluids In place Consider
stopping
Eating and
Drinking
jejunostomy
feed 30ml/hr
Sips of water
up to 100ml
per hour
Free Fluids Start full diet as
per dietician
advice.
Overnight
feed via
jejunostomy
Dietitian review
as to need
for overnight
jejunostomy
feeding at home
Wound Care Change drain
dressings Surgical
wounds checked
& dressings
changed if
necessary
Leave surgical
wound
undressed,
if dry and
healing well
Investigations Chest X-Ray
recovery
Chest X-Ray Chest X-Ray Chest X-Ray Chest X-Ray Chest X-Ray
FBC, U&E FBC, U&E FBC, U&E, CRP FBC, U&E FBC, U&E, CRP FBC, U&E
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high-volume regional tertiary referral centre for oesophago-gastric
resections.Table 2
Accordion Severity Grading System (ASGS) for postoperative complications [11].
Severity Grade
1 Mild complication Requires only minor invasive procedures
at the bedside
2 Moderate complication Requires pharmacological treatment
such as antibiotics
3 Moderate complication Requires management by endoscopic
intervention or intervention without anaesthesia
4 Severe complication Requires management by a procedure under
general anaesthesia
5 Severe complication Organ system failure
6 Death Postoperative death within 30 days
The ASGS provides a framework for complication assessment which is based on
grading the complexity of therapy for the complication.2. Methods
An ERAS programme was devised to standardise the admission
process and postoperative management of oesophagectomy pa-
tients with a principle aim of reducing inpatient stay whilst
maintaining or improving outcomes. The ERAS programme was
designed over a series of meetings involving a task-force of repre-
sentatives from all aspects of patient care, principally oesophago-
gastric surgeons, specialist anaesthetists, cancer specialist nurses,
theatre staff, dieticians, physiotherapists, senior nursing staff,
directorate managers and a Trust appointee for the implementation
of ERAS programmes. The ﬁnalised ERAS programme (adapted with
Table 3
Median total length of stay and length of stay for pre-ERAS, ERAS and non-ERAS
groups.
Number of
patients
Total length of stay
(days)
Postoperative
length of stay (days)
Pre-ERAS 80 13 r.8e57
(P ¼ <0.001)
12 r.7e56 (P ¼ <0.001)
ERAS 75 10 r.7e58 10 r.7e58
Non-ERAS 41 13 r.8e42
(P ¼ <0.001)
12 r.8e41 (P ¼ 0.002)
All comparisons made to ERAS group.
Table 4
Accordion Severity Grading System (ASGS) for postoperative complications and
anastomotic leak rate by group.
ASGS score ERAS (75) Non-ERAS (41) Pre-ERAS (80)
0 27 (36%) 20 (48%) p ¼ 0.3 38 (48%) p ¼ 0.26
1e3 37 (49%) 12 (29%) p ¼ 0.11 25 (31%) p ¼ 0.07
4e5 11 (15%) 9 (22%) p ¼ 0.6 16 (20%) p ¼ 0.42
6 0 (0%) 0 (0%) 1 (1.3%) p ¼ 0.33
Anastomotic leak 3 (4%) 2 (5%) 11 (14%) p = 0.05
All comparisons made to ERAS group.
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designed to be a standardised pathway independent of which
weekday the operation occurred upon. Crucially all patients were
informed of the process before admission and encouraged to
document and take ownership of their progress. Preoperative
assessment was centralised to facilitate admission on the day of
surgery. The ERAS programme (Table 1) was introduced in October
2011 with three consultant oesophago-gastric surgeons allocating
consecutive patients to the ERAS programme and two surgeons
continuing with their established postoperative instruction. Thus
for analysis, three patient groups exist: consecutive patients prior
to the introduction of the ERAS programme (pre-ERAS) (July 2010e
September 2011); consecutive patients enrolled on the ERAS pro-
gramme (ERAS) (October 2011eJuly 2013) and patients not enrolled
on the ERAS programme but treated during this time-frame (non-
ERAS) (October 2011eJuly 2013). All patients undergoing two-stage
open or laparoscopically assisted ILOG were included in the study.
Independent variables included for analysis were: treatment
group, patient age, total length of hospital stay (TLOS), post-
operative length of stay, operative abdominal approach, Accordion
Severity Grading System (ASGS) for postoperative complications
[11] (Table 2), radiologically conﬁrmed anastomotic leak and 30-
day re-admission rate.
Continuous datawere analysed using the ManneWhitney U test
and dichotomous data were compared using X2 and Fisher’s exact
test. All P values reported were two-tailed and P < 0.05 was
considered to be statistically signiﬁcant. SPSS version 18 (IBM,
Armonk, New York, USA) and Baseline 100 (SAA Software, UK) were
used for statistical analysis.
3. Results
The ERAS task-force identiﬁed multiple areas for improving and
streamlining the care pathway from preoperative assessment to
recovery. Day of surgery admission was introduced, with patients
having been pre-assessed and engaged in a brief educationalFig. 1. Statistical process control chart illustrating total length of stay over time before
and after the introduction of ERAS.session regarding the ERAS programme and anticipated goals. Oral
sips of water (maximum 100 ml/h) were initiated from the day of
surgery. Routine contrast swallow radiology was removed (previ-
ously performed on postoperative day 4e6 depending on timing of
the weekend). Incentive spirometry, early drain removal and
modiﬁed dietary goals were also introduced (Table 1). A policy of
immediate extubation and postoperative management in a dedi-
cated monitored ward bed with a paravertebral block for lapa-
roscopically assisted ILOG or a thoracic epidural for open abdominal
procedures had already been established prior to the introduction
of the ERAS programme.
Eighty consecutive patients were studied in the pre-ERAS group,
75 patients were enrolled on the ERAS programme and 41
continued as the non-ERAS group over a 21-month period. Data
was available for all patients and nonewere excluded. No difference
in median age was noted between the pre-ERAS, ERAS and non-
ERAS groups: 68 (range 44e82), 67 (range 34e86) and 66 (range
31e84) years respectively.
The abdominal phase of the ILOG was different between the
groups with signiﬁcantly more patients in the ERAS group having a
laparoscopically assisted abdominal phase: number of lapa-
roscopically assisted procedures; ERAS 58 (77%) versus pre-ERAS 38
(48%) and none in the non-ERAS group (P¼<0.001 and P¼<0.001
respectively).
Signiﬁcant improvements in TLOS and postoperative length of
stay were observed with the introduction of the ERAS programme
(Table 3). Median TLOS in the pre-ERAS group was 13 days (range
8e57) compared to just 10 days (range 7e58) for those following
the ERAS programme (P ¼ <0.001). Median TLOS for the non-ERAS
group was 13 days (range 8e42), signiﬁcantly longer than the ERAS
group (P ¼ <0.001). A signiﬁcant reduction in postoperative length
of stay was recorded with the introduction of the ERAS programme
with a median postoperative length of stay in the ERAS group of 10
days (range 7e58) compared to 12 for the pre-ERAS group (range
7e56) (P ¼ <0.001) and 12 days for the non-ERAS group (range 8e
41) (P ¼ 0.002).
A statistical process control chart (Fig. 1) for pre-ERAS and ERAS
group TLOS (ASGS  4 excluded) demonstrated a progressive and
stable fall in TLOS with the introduction of ERAS.
The operative approach to the abdominal phase of the ILOG
(open or laparoscopically assisted) did not signiﬁcantly inﬂuence
TLOS in either the pre-ERAS or ERAS groups.
The ASGS score for postoperative complications was broken
down into no complications (score 0), mild to moderate compli-
cations (score 1e3), severe complications (score 4e5) and post-
operative death (score 6). No signiﬁcant increase or decrease in
postoperative complications was recorded with the introduction of
ERAS compared to the pre-ERAS era or non-ERAS patients (Table 4).
1 postoperative death occurred in the pre-ERAS group. The ERAS
group suffered signiﬁcantly fewer radiologically conﬁrmed anas-
tomotic leaks than the pre-ERAS group: 3 (4%) versus 11 (14%)
respectively P¼ 0.05. No difference in the incidence of leak ratewas
observed between the ERAS and non-ERAS groups: 3 (4%) and 2
(5%) respectively.
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recorded between the groups with 10 patients (13%) re-admitted
from the ERAS group compared to 10 patients (11%) before the
introduction of the ERAS programme and 3 patients (7%) in the
non-ERAS group.4. Discussion
The current era of severe ﬁnancial constraint and ever
increasing demand for healthcare is a potent evolutionary driver for
the efﬁcient use of resources whilst maintaining or improving
clinical standards. Upper gastrointestinal cancer services have been
centralised to create regional high volume centres in the pursuit of
improved outcomes [2]. However, even after minimally invasive
oesophagectomy, the reported median length of stay is 15 days in
the UK [12] and is highly variable [3,9]. The multidisciplinary
approach to cancer staging, patient selection and choice of proce-
dure lends itself to the introduction of standardised clinical care
pathways with attendant improvements in patient care [13,14].
However, despite the clear beneﬁts of ERAS programmes, now
enshrined in the management of colorectal resections [8], the
postoperative management of oesophagectomy patients remains
highly idiosyncratic and variable. Nonetheless, a small number of
reports describing a success reduction in postoperative stay after
oesophagectomy, often as part of a wider standardised clinical
pathway or involving limited numbers of patients have been pub-
lished [6,13,15].
The design, evolution and implementation of an ERAS pro-
gramme requires considerable dedication and crucially consulta-
tion with key stakeholders and representatives from all disciplines
involved in patient care. Departure from historical perceptions of
the postoperative management of oesophagectomy patients is in-
tegral to enhanced recovery and goal directed daily targets, with
patient co-operation, are essential to prevent “drift” from the
programme. However, inevitably postoperative complications
occur that necessitate temporary deviation from the ERAS pro-
gramme. The success of an ERAS programme is multi-factorial.
Some of the key changes introduced within the ERAS programme
were the introduction of day of surgery admission, the institution of
oral water intake immediately after the operation, elimination of a
routine contrast study and timely drain removal. Prior experience
of immediate extubation, transfer to a dedicated monitored ward
bed and early mobilisation coupled with regional anaesthesia
techniques undoubtedly facilitated the application of ERAS and
helped create the appropriate patient mind-set. Paravertebral
blocks avoid the potential hypotensive sequelae associated with
thoracic epidurals that can delay early mobilisation and complicate
postoperative ﬂuid balance [16]. Patient admission on the morning
of surgery eliminated an unnecessary night in hospital and avoided
the anxiety of waiting for bed availability and ward based preop-
erative assessment.
The ERAS programme is now ﬁrmly established in our institu-
tion with 75 consecutive patients successfully enrolled over a 21-
month period. The ERAS programme reduced the median total
length of stay by 3 days compared to pre-ERAS patients, equating to
a considerable cost saving and reduction in resource allocation. The
fall in TLOS observed after the introduction of ERAS became
increasingly stable with reduced variation when plotted on a sta-
tistical process control chart (Fig. 1). The lack of change in TLOS and
length of stay, observed in the non-ERAS group compared to pre-
ERAS patients, strongly supports the conclusion that the reduced
length of stay in the ERAS group is attributable to the introduction
of the ERAS programme rather than simply a function of the time
period studied.The ERAS programme was safely introduced with no impact on
30-day readmission, postoperative morbidity or mortality rates
compared to pre-ERAS and non-ERAS patients. Patients following
the ERAS programme had a signiﬁcantly lower rate of anastomotic
leak than the pre-ERAS group. However, the small number of pa-
tients involved, lack of difference in leak rate between the ERAS and
non-ERAS groups and the removal of routine postoperative contrast
studies, as part of the ERAS programme, prevents interpretation of
the possible inﬂuence of the ERAS programme on leak rate.
One of the perceived potential beneﬁts of a laparoscopically
assisted ILOG is the reduction in length of hospital stay due to a
more rapid recovery [17,18]. The percentage of patients enrolled on
the ERAS programme undergoing a laparoscopic abdominal
approach was signiﬁcantly higher than either the pre-ERAS or non-
ERAS cohorts. The initial impression may therefore be that any
reduction in TLOS in the ERAS cohort is simply a reﬂection of amore
minimally invasive procedure. However, within the ERAS group,
those receiving a laparoscopically assisted ILOG demonstrated no
difference in median TLOS suggesting that within the context of an
ERAS programme, any potential beneﬁt from minimally invasive
surgery on reduced length of stay may be lost.
The introduction of an ERAS programme after ILOG can signiﬁ-
cantly reduce the length of inpatient recovery without jeopardising
patient safety or clinical outcomes. The design, implementation,
evaluation and revision of a successful ERAS programme requires
the involvement and dedication of all disciplines concerned with
patient care. An ERAS programme must blend seamlessly with
optimised peri-operative patient management and requires the full
motivation of all team members and the patient.
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